Knowledge Centers
-
Driver of neurodegenerative diseases revealed
In searching for how a gene mutation associated with the cell’s recycling center leads to a rare disease, the team identified a missing link in neurodegenerative conditions
September 14, 2023
-
Entrepreneurial undergrads tackle ovarian cancer
With funding and support from ChEM-H, a team of undergrads is bringing their idea to kickstart the body’s immune system closer to reality.
December 06, 2021
-
Stanford single-dose nanoparticle vaccine for COVID-19
Researchers at Stanford are working to develop a single-dose vaccine for SARS-CoV-2 that could potentially be stored at room temperature.
January 05, 2021
-
Carolyn Bertozzi named Baker Family Director of Stanford ChEM-H
Chemistry Professor Carolyn Bertozzi says recruiting world-class scientists and engineers and developing ChEM-H into a hub where doctors and researchers can come together.
November 11, 2020
-
Jeffrey Glenn granted $14.3 million to develop broad spectrum drugs
Researchers are pursuing antiviral drugs with broad efficacy against enteroviruses, which cause common colds and polio, and coronaviruses including the one that causes COVID
October 05, 2020
-
The Innovative Medicines Accelerator turns its focus on COVID-19
Stanford’s new IMA arose before the COVID-19 pandemic struck, but now its programs are focused entirely on helping faculty generate and test new medicines to slow the spread.
May 21, 2020
-
ChEM-H researchers work toward new understanding of cancer camouflage
A group led by ChEM-H Institute Scholar Lingyin Li and Chemistry/Biology Interface graduate student Jacqueline Carozza found a molecule that could help undermine cancer's defenses.
February 24, 2020
-
Antiviral treatments lead researchers to develop possible cancer drug
An effort to thwart viral diseases like hepatitis or the common cold led to a new collaboration and a novel class of cancer drugs that appears effective in mice.
January 23, 2020
-
Stanford researchers probe the link between gut microbiota and cancer immunotherapy
Immunotherapy has great promise as a cancer treatment, but current therapies only work in some. Researchers found that microorganisms in our guts might be the deciding factor.
August 27, 2019
-
Integrating Medicine with Basic Science
Justin Annes, MD, PhD, assistant professor of endocrinology, gerontology and metabolism, feels that he owes a great deal of credit for his unique research program to the ChEM-H
March 05, 2019
-
Zinc chelation may be able to deliver drug to insulin-producing cells
By delivering a drug directly to beta cells, researchers may be able to spur insulin production and potentially develop a diabetes therapy in the future.
December 11, 2018
-
Researchers use zinc to target insulin-producing cells with regenerative drug
To treat diabetes directly, doctors need a way to get drugs to cells that produce insulin. The key, Stanford researchers report, may be those cells’ affinity for zinc.
December 06, 2018
-
A tale of cacao, birds and the ‘power of emerging model systems’
Tracing the genetic process through which parakeets produce either yellow or blue feathers has given Stanford scientists insights that could uncover other biochemical pathways.
October 05, 2017
-
Stars of Stanford Medicine: “I want to leave an impact on medical care”
Physician-scientist Justin Annes specializes in a rare type of tumor disorders. He shares his story, and interests, in this Stars of Stanford Medicine Q&A.
September 28, 2017
-
The exploding cucumber plant delivers inspiration for a new weapon against cancer
Nick Cox, a ChEM-H Medicinal Chemistry Knowledge Center postdoc scholar, and Jennifer Cochran lab develop a novel, harmless molecular warhead to deliver drugs to cancer cells.
September 30, 2016
-
Your one-stop shop for producing, crystallizing biomolecules
Macromolecular Structure Knowledge Center to help researchers who lack equipment for testing different crystallization conditions or expertise in working with challenging molecules
April 21, 2016
-
Decoy drug could prevent cancer's spread
Creating a molecular snapshot of the way proteins interact could help development of new cancer drugs.
March 31, 2016
-
Masters of Crystallization
When molecules won't crystallize and technology confounds, who you gonna call?
March 24, 2016
-
$28 million grant launches Center of Excellence for Translation Research
Jeffrey Glenn, MD, PhD, is leading a new center to develop antiviral therapies that target the host cell instead of the virus.
June 09, 2014